Morgan Stanley Targets New All-Time High For Bristol-Myers, Upgrades To Overweight
February 15, 2018 at 09:38 AM EST
Bristol-Myers Squibb Co (NYSE: BMY) stock is up 26.5 percent year-over-year, making a partial recovery from a mid-2016 plunge, and one ...
